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Overview of the Thesis 
This thesis is presented in seven chapters. Some of these chapters are based on publications that 
are either under review or under consideration for publication in peer-reviewed journals.  
Chapter One: This is the introduction chapter of this thesis. This chapter outlines the 
background, rationale and outcomes for this study along with the significance and research 
questions under study. 
Chapter Two: This chapter presents a systematic review of randomised controlled trial studies 
describing the best available evidence on the effectiveness of interventions suitable for delivery 
by nurses, designed to enhance cardiac patients’ adherence to their prescribed medications. This 
chapter is based on a published paper: (Al‐Ganmi et al. 2016). 
Chapter Three: This chapter presents survey results determine and compare the level of 
adherence to cardiac medications and factors predictive of medication adherence in patients 
with cardiovascular disease admitted to a cardiac ward or attending cardiac rehabilitation in 
Australia. This chapter is based on a revised version of the second paper was submitted to the 
Journal of Nursing and Health Sciences: Al-Ganmi A., Perry L., Gholizadeh L., & Alotaibi A., 
(2019) Medication adherence and predictive factors in patients with cardiovascular disease in 
Australia. Revised version submitted to Journal of Nursing and Health Sciences.  
Chapter Four: This chapter presents the findings of the multi-centre comparison study 
evaluated and compared adherence to cardiac medications and potentially predictive factors based on 
the Theory of Planned Behaviour (TPB) in patients with cardiovascular disease admitted to hospital and 
attending cardiac services in Australia and Iraq. This chapter is based on a paper published in 
Collegian: (Al-Ganmi et al. 2019). 
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Chapter Five: This chapter presents the proposed protocol, designed to pilot an RCT as a 
suitable test of the effectiveness of an evidence-based, nurse-led intervention in promoting of 
medication adherence. This chapter is based on a published paper: (Al-Ganmi et al. 2018). 
Chapter Six: This chapter presents the overall discussion of the main findings of the two 
surveys of this study and wraps up the findings of this thesis in relation to its strengths and 
limitations.  
Chapter Seven: This chapter presents the conclusions of this study and sets out the implications 
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Definition of Terms for this thesis 
Adherence 
The extent to which the patient’s behaviour matches agreed recommendations by the 
prescriber (Horne et al. 2005). 
Adherence (Operational Definition) 
The extent to which a patient takes prescribed medications according to the dosage and 
frequency recommended by the provider (Vrijens et al. 2012).  
 Medication Adherence 
The extent to which a person’s behaviour (taking medications, following a 
recommended diet and/or executing lifestyle changes) corresponds with the agreed 
recommendations of a healthcare provider’ (Sabaté 2003).  
Health Behaviour:  
An action taken by a person to maintain, attain, or regain good health and to prevent 
illness. Health behaviour reflects a person’s health beliefs (Mosby’s Medical Dictionary 
2009).  
Behaviour Change  
A broad range of activities and approaches which focus on the individual, community, 
and environmental influences on behaviour (Stedman's Medical Dictionary for the 







A structural or functional abnormality of the heart, or of the blood vessels supplying the 
heart, that impairs its normal functioning (The American Heritage Medical Dictionary 
2007). 
Cardiovascular Disease (CVD) 
Any disease that affects the cardiovascular system, principally cardiac disease, vascular 
disease of the brain and kidney, and peripheral arterial disease (Fuster & Kelly 2010).  
Coronary artery disease (CAD), Coronary Heart Disease (CHD), or Ischaemic 
Heart Disease (IHD) 
Narrowing of the lumen of one or more of the coronary arteries, usually due to 
atherosclerosis; leading to angina pectoris, myocardial infarction or congestive heart 
failure (Stedman 2005). 
Acute Coronary Syndrome (ACS) 
A classification encompassing clinical presentations ranging from unstable angina 
through myocardial infarctions not characterised by alteration in Q waves. The 
classification sometimes also includes myocardial infarctions characterised by altered 
Q waves (Mosby’s Medical Dictionary 2009). 
Self-Efficacy 
A person’s estimate or personal judgment of his or her own ability to succeed in 
reaching a specific goal, for example continuing at a prescribed weight level (Farlex 






Introduction: Cardiovascular disease (CVD) is the leading cause of mortality 
worldwide, with medication non-adherence a suboptimal, poorly prioritised and 
challenging health problem in both developed and developing nations. Treatment of 
CVD for most patients comprises lifelong lifestyle changes and regular medication. 
Adherence to recommended treatment can be promoted by nurse-led interventions.  
Aim: The overarching aims of this thesis were to develop a widely-applicable, 
evidence-based nurse-led intervention tailored to address factors predictive of poor 
adherence to medication regimes in patients with CVD who had been admitted to an 
acute hospital as an acute cardiac care or those who attend cardiac rehabilitation, and to 
design a protocol to trial this intervention. Objectives were: 
Paper 1: To critically appraise and synthesise the best available evidence on the 
effectiveness of interventions suitable for delivery by nurses, designed to enhance 
cardiac patients’ adherence to their prescribed medications.  
Paper 2: To identify factors predictive of medication adherence in patients with 
cardiovascular disease admitted or attending hospital in Australia.  
Paper 3: To compare factors associated with medication non-adherence in patients with 
CVD in developed and developing nations (Australia and Iraq). 
Paper 4: To design a protocol suitable to test the effectiveness of an evidence-based 
nurse-led intervention in promotion of medication adherence in patients with CVD who 
admit to in-patient for acute cardiac care or those who attend cardiac rehabilitation.  
Methods: Using established methods, a systematic review was conducted to identify 
effective nurse-led medication adherence interventions for patients with CVD. Cross-
xxi 
 
sectional surveys were conducted with 120 and 126 patients with CVD who were 
inpatients of a cardiac ward or attending cardiac out-patient care in acute tertiary 
hospitals in Sydney, Australia and Baghdad, Iraq, respectively. Medication adherence 
was assessed using the Medication Adherence Questionnaire; factors potentially 
predictive of medication non-adherence were assessed using validated instruments and 
modelled using regression analysis. A pilot randomised controlled trial was proposed 
to test the hypothesis that a theory-based, nurse-led, multi-faceted intervention 
comprising motivational interviewing techniques and text message reminders can 
enhance medication adherence in cardiac patients compared to standard care alone.  
Results: Systematic review findings suggested that nurse-led interventions applying 
motivational interviewing and text messaging offer most promise. In the Australian 
study, participants from cardiac rehabilitation reported significantly lower adherence 
than ward in-patients. The comparative study showed significantly poorer adherence to 
cardiac medications in Iraqi than Australian patients. The ability to correctly self-
administer and refill medications, and beliefs about medications, independently 
predicted cardiac medication adherence behaviour in both countries. 
Conclusion: Nurse-led interventions that incorporate elements of motivational 
interviewing plus text messaging have the potential to improve medication adherence 
of patients with CVD through targeting patients’ ability to self-administer and refill 
medications and their beliefs about these medications. 
